Skip to main content

03.05.2024 | Research

Risk factors for acute kidney injury in very-low birth weight newborns: a systematic review with meta-analysis

verfasst von: Lucas Hirano Arruda Moraes, Vera Lúcia Jornada Krebs, Werther Brunow de Carvalho

Erschienen in: European Journal of Pediatrics

Einloggen, um Zugang zu erhalten

Abstract

This study aims to analyze the main risk factors for acute kidney injury in the subgroup of very-low birth weight newborns, using the diagnosing criteria of the Kidney Disease Improving Global Outcomes (KDIGO) or the Acute Kidney Injury Network (AKIN). A systematic review of the literature was performed on the EMBASE® and PubMed® platforms. Studies that evaluated the risk factors for developing AKI in VLBW newborns were included. For the meta-analysis, we only included the risk factors that were associated with AKI in the univariate analysis of at least two studies. After an initial screening, abstract readings, and full-text readings, 10 articles were included in the systematic review and 9 in the meta-analysis. The incidence of AKI varied from 11.6 to 55.8%. All the studies have performed multivariate analysis, and the risk factors that appeared most were PDA and hemodynamic instability (use of inotropes or hypotension), sepsis, and invasive mechanical ventilation. After the meta-analysis, only cesarian delivery did not show an increased risk of AKI, all the other variables remained as important risk factors. Moreover, in our meta-analysis, we found a pooled increased risk of death in newborns with AKI almost 7 times.
 Conclusion: AKI in VLBW has several risk factors and must be seen as a multifactorial disease. The most common risk factors were PDA, hemodynamic instability, sepsis, and invasive mechanical ventilation.
What is known:
• Acute kidney injury is associated with worst outcomes in all ages. It´s prevention can help diminish mortality.
What is new:
• A synthesis of the main risk factors associated with AKI in very low birth weight newborns.
Literatur
2.
Zurück zum Zitat Kavanaugh KJ, Jetton JG, Kent AL (2021) Neonatal acute kidney injury: understanding of the impact on the smallest patients. Crit Care Clin 37:349–363CrossRefPubMed Kavanaugh KJ, Jetton JG, Kent AL (2021) Neonatal acute kidney injury: understanding of the impact on the smallest patients. Crit Care Clin 37:349–363CrossRefPubMed
3.
Zurück zum Zitat Harer MW, Selewski DT, Kashani K et al (2021) Improving the quality of neonatal acute kidney injury care: neonatal-specific response to the 22nd Acute Disease Quality Initiative (ADQI) conference. J Perinatol 41:185–195CrossRefPubMed Harer MW, Selewski DT, Kashani K et al (2021) Improving the quality of neonatal acute kidney injury care: neonatal-specific response to the 22nd Acute Disease Quality Initiative (ADQI) conference. J Perinatol 41:185–195CrossRefPubMed
7.
Zurück zum Zitat Wu Y, Wang H, Pei J et al (2022) Acute kidney injury in premature and low birth weight neonates: a systematic review and meta-analysis. Pediatr Nephrol 37:275–287CrossRefPubMed Wu Y, Wang H, Pei J et al (2022) Acute kidney injury in premature and low birth weight neonates: a systematic review and meta-analysis. Pediatr Nephrol 37:275–287CrossRefPubMed
11.
Zurück zum Zitat Kuo J, Akison LK, Chatfield MD et al (2022) Serum and urinary biomarkers to predict acute kidney injury in premature infants: a systematic review and meta-analysis of diagnostic accuracy. J Nephrol 35:2001–2014CrossRefPubMedPubMedCentral Kuo J, Akison LK, Chatfield MD et al (2022) Serum and urinary biomarkers to predict acute kidney injury in premature infants: a systematic review and meta-analysis of diagnostic accuracy. J Nephrol 35:2001–2014CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRefPubMed Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRefPubMed
27.
Zurück zum Zitat Matsushita FY, Krebs VLJ, de Carvalho WB (2022) Association between fluid overload and mortality in newborns: a systematic review and meta-analysis. Pediatr Nephrol 37:983–992CrossRefPubMed Matsushita FY, Krebs VLJ, de Carvalho WB (2022) Association between fluid overload and mortality in newborns: a systematic review and meta-analysis. Pediatr Nephrol 37:983–992CrossRefPubMed
Metadaten
Titel
Risk factors for acute kidney injury in very-low birth weight newborns: a systematic review with meta-analysis
verfasst von
Lucas Hirano Arruda Moraes
Vera Lúcia Jornada Krebs
Werther Brunow de Carvalho
Publikationsdatum
03.05.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-024-05593-5

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.